Quantcast
Latest Stories

Study ties drug shortage to poorer cancer survival

By

A bottle of mechlorethamine under the brand name Mustargen. A new study gives the best evidence so far that cancer patients are suffering because of shortage of drugs such as mechlorethamine, or nitrogen mustard, which had been in short supply until November 2012, when more became available. PHOTO FROM MEDICALOOK.COM

Young cancer patients who couldn’t get a key medicine because of a US-wide drug shortage were more likely to suffer a relapse than others who were able to get the preferred treatment, doctors report. It’s the first evidence that a longstanding drug-supply problem probably has affected cancer treatment results in specific patients.

The study involved more than 200 children and young adults with a blood cancer called Hodgkin lymphoma. Like childhood leukemia, it can be cured nearly 80 percent of the time. But a drug shortage that has worsened since 2009 is threatening that success rate, doctors report in Thursday’s New England Journal of Medicine.

Hundreds of drugs, including sedatives, antibiotics, painkillers and cancer treatments, have gone in and out of short supply in recent years. Reasons include manufacturing and contamination problems, plant shutdowns, and fewer makers and lower profits for certain drugs, especially generics infused during surgery or cancer treatment.

Doctors sometimes substitute different drugs for ones in short supply. But proving that the swaps led to poorer results has been tough, especially for cancer patients whose disease and response to treatment vary so much.

“We really couldn’t put our finger on, did anybody really suffer?” said Dr. Michael Link, a cancer specialist at Stanford University and past president of the American Society of Clinical Oncology.

The new study, led by Dr. Monika Metzger of St. Jude Children’s Research Hospital in Memphis, gives the best evidence so far that patients are suffering.

It focused on mechlorethamine, or nitrogen mustard, a drug that has been in short supply until last month, when more became available. Doctors compared results among 181 Hodgkin lymphoma patients who received the drug to 40 others who were given a different chemotherapy, cyclophosphamide, when the first choice was unavailable.

Only 75 percent of those given the substitute drug stayed free of cancer for two years versus 88 percent who received the preferred treatment.

“We can think of no credible explanation for this dramatic difference” other than the drug substitution, the authors wrote.

No patients died, but those who relapsed were given more aggressive treatments, including stem-cell transplants that have more side effects and can harm fertility.

One of them was Abby Alonzo, of Port St. Lucie, Florida. She was diagnosed with lymphoma three years ago, when she was 10. After eight weeks of treatment with the preferred drug, “she was doing wonderfully,” said her mother, Katie Alonzo.

Then doctors said they were out of it.

“I said, what do you mean, we don’t have the medication my child needs?” Katie Alonzo said.

After four weeks on the substitute chemo, Abby’s cancer had returned and spread to more places, her mother said. The child received high doses of chemotherapy and radiation and now seems cancer-free, although the treatments damaged her lung capacity, leaving her short of breath.

“When your child has cancer you live day by day,” and to find out a life-saving medicine isn’t available is “very, very frightening,” Katie Alonzo said.

Follow Marilynn Marchione at http://twitter.com/MMarchioneAP


Follow Us


Follow us on Facebook Follow on Twitter Follow on Twitter


Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Tags: cancer , diseases , Drug Shortage , US

  • http://www.facebook.com/chatlanegrace.computercenter Chatlanegrace Computercenter

    guyabano lang ang katapat ng cancer and other herbal medicine.  Madami akong kakilala na mayaman na ng magka-cancer, tigok agad nang magpachemo. Pero yung mga kakilala ko na mahirap na nagcacancer, porket walang pera nag-guyabano o minom ng herbal medicines, ayun gumaling sa sakit.

  • UrHONOR

    A very sad state, indeed.  Kahit na mahal ang mga gamot, tulad ng Chemo treatment na nagkakahalaga ng mahigit na $7,000-10,000/shot at ang radiation na halos $2,500-$5000/treatment, hindi pa ito eadily available.  Ang Epogen lamang, $5,000 at least per vial of 5,000.  Talagang ka-awa-awa ang magkaroon ng cancer ng kahit na anong uri…bukod sa masakit na, ang laki-laking halaga pa ang kinakailangan.  Sa ating bayan, kapag nagkaroon ka ng cancer, mabuti ng magbilang ka na lang ng araw mo kaysa sa umasa ka pang gumaling under the present circumstances.  

    KAYA mag-ingat ng mabuti sa kung ano ang pinapasok sa katawan…lalo na ang mga karneng baka’t baboy na madalas i-bar-b-que na hindi lutong-luto o sobra ang pagka-luto na nagiging sunog kung saan mataas ang carcinogen na pinagmumulan ng cancer sa colon.  But, however careful and watchful we are for our health, we will end up the same way as anyone else—6 feet under the ground or in an urn,  So, ENJOY to the hilt the present time within bounds while you can. 



Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94
Advertisement
Advertisement

News

  • Gloomy weather on Black Saturday–Pagasa
  • Mixed feelings for Gabriel Garcia Marquez in hometown
  • Korea ferry captain arrested, divers spot bodies
  • Enrile chief aide back in PH ‘to face charges’–report
  • Pakistan library named ‘bin Laden,’ as memory fades
  • Sports

  • Duke’s Rodney Hood joining Jabari Parker in NBA draft
  • Phelps entered in 3 events at comeback meet
  • Boston prepares for huge wave of marathon visitors
  • Motivated LeBron James preps for postseason
  • Nadal ousted by Ferrer in Monte Carlo quarters
  • Lifestyle

  • Levine designs womenswear with help from fiancee
  • Gabriel Garcia Marquez, Nobel laureate, dies at 87
  • Ford Mustang turns 50 atop Empire State Building
  • Pro visual artists, lensmen to judge Pagcor’s photo contest
  • ‘Labahita a la bacalao’
  • Entertainment

  • Myx TV premieres Asian American ‘docu-series’
  • A nutty finale for ‘Scandal,’ TV’s craziest show
  • EXO postpones release of mini album ‘Overdose’
  • ‘X-men’ filmmaker slams ‘fabricated’ sex attack claims
  • Singer Chris Brown’s bodyguard on trial in DC
  • Business

  • US commerce secretary spells out economic facet of ‘pivot to Asia’
  • Italy sells luxury state cars on eBay
  • Asian shares mostly up in quiet trade
  • Dollar up in Asia on US jobs data, Ukraine deal
  • Barbie doll has a problem
  • Technology

  • Nasa’s moon-orbiting robot crashes down
  • Netizens pay respects to Gabriel Garcia Marquez
  • Nokia recalls 30,000 chargers for Lumia 2520 tablet
  • Facebook rolls out ‘nearby friends’ feature
  • Netizens seethe over Aquino’s ‘sacrifice’ message
  • Opinion

  • Editorial cartoon, April 17, 2014
  • A humbler Church
  • Deepest darkness
  • ‘Agnihotra’ for Earth’s health
  • It’s the Holy Week, time to think of others
  • Global Nation

  • OFW from UAE tests negative for MERS-Cov–health chief
  • Multicultural flock marks Good Friday in San Francisco
  • Las Vegas ‘Pinoy Pride’ fest hails Filipino heritage
  • Marking Jesus’ journey on Good Friday
  • Filipina accomplice arrested for fake bills in Malaysia
  • Marketplace